CANCIDAS
MERCK CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CANCIDAS discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CANCIDAS 50MG has been permanently discontinued (last updated April 15, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CANCIDAS not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
CASPOFUNGIN ACETATE FOR INJECTION
STERIMAX INC
CANCIDAS
MERCK CANADA INC
CASPOFUNGIN POWDER FOR INJECTION
TEVA CANADA LIMITED
CASPOFUNGIN FOR INJECTION
JUNO PHARMA CANADA INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02244265
Strength
50MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Active Ingredient
CASPOFUNGIN
Tier
Unrated
Last Updated
2026-04-15
Reason for Shortage
Business reasons
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
10MG · DIN 02483513
20MG · DIN 02483548
15MG · DIN 02483521
100MG · DIN 02451816
70MG · DIN 02244266
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00688622
0.05% · DIN 00862975
80MG · DIN 02298791